The overexpression of MEG3 resulted in increased breast cancer cell apoptosis, not only via upregulating the ER-stress and proapoptotic proteins, but by activating the NF-κB and p53 signaling pathways. This evidence concerns the gene MEG3 and breast carcinoma.